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Abstract
Background: Two important aspects for the development of anxiety disorders are genetic predisposition and
alterations in the hypothalamic-pituitary-adrenal (HPA) axis. In order to identify genetic risk-factors for anxiety, the
aim of this exploratory study was to investigate possible relationships between genetic polymorphisms in genes
important for the regulation and activity of the HPA axis and self-assessed anxiety in healthy individuals.
Methods: DNA from 72 healthy participants, 37 women and 35 men, were included in the analyses. Their DNA was
extracted and analysed for the following Single Nucleotide Polymorphisms (SNP)s: rs41423247 in the NR3C1 gene,
rs1360780 in the FKBP5 gene, rs53576 in the OXTR gene, 5-HTTLPR in SLC6A4 gene and rs6295 in the HTR1A gene.
Self-assessed anxiety was measured by the State and Trait Anxiety Inventory (STAI) questionnaire.
Results: Self-assessed measure of both STAI-S and STAI-T were significantly higher in female than in male
participants (p = 0.030 and p = 0.036, respectively). For SNP rs41423247 in the NR3C1 gene, there was a significant
difference in females in the score for STAI-S, where carriers of the G allele had higher scores compared to the
females that were homozygous for the C allele (p < 0.01). For the SNP rs53576 in the OXTR gene, there was a
significant difference in males, where carriers of the A allele had higher scores in STAI-T compared to the males
that were homozygous for the G allele (p < 0.01).
Conclusion: This study shows that SNP rs41423247 in the NR3C1 gene and SNP rs53576 in the OXTR gene are
associated with self-assessed anxiety in healthy individuals in a gender-specific manner. This suggests that these
SNP candidates are possible genetic risk-factors for anxiety.
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Background
Anxiety disorders are complex disorders defined by excess
worry, hyperarousal, and fear that are counterproductive
and debilitating [1]. Such disorders globally associate with
socio-economic disadvantages, high demands at work, rela-
tionship difficulties, trauma and conflict [2], indicating that
stressful events are major contributors to the development
of anxiety disorders. The biological bases of these disorders
depend partly on alterations in the hypothalamic-pituitary-
adrenal axis (HPA axis). The HPA axis coordinates bodily
reactions to stressful events and restores homeostasis. In
response to stress, a hormonal cascade is triggered in the
hypothalamus, where the release of corticotrophin-
releasing hormone (CRH) stimulates the secretion of adre-
nocorticotropic hormone (ACTH) from the pituitary.
Further in the signaling pathway to peripheral organs,
ACTH then induces glucocorticoid (GC) synthesis in the
adrenal glands [3]. Released GCs bind to intracellular
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glucocorticoid receptors (GRs), which after ligand binding
translocate to the nucleus and thereby modify the expres-
sion of genes to help maintain homeostasis [4].
The activity of the HPA axis is regulated both through
negative feedback from its own hormones and through
neurotransmitters such as serotonin and oxytocin [5].
Serotonin is released from serotonin neurons ascending
from the raphe nucleus in the midbrain to the paraven-
tricular nucleus (PVN) in the hypothalamus [6], where it
increases HPA axis activity. In contrast oxytocin, which
is released from the posterior pituitary, decreases activity
in the HPA axis and thereby acts as a buffering neuro-
peptide on the stress response. This helps the individual
to restore homeostasis. Oxytocin also affects serotonin
release in the amygdala by activation of oxytocin recep-
tors expressed in serotonergic neurons [7, 8].
Genetic predisposition is another important aspect in
the development of anxiety disorders, for which a herit-
ability of approximately 30 to 50% has been reported [9].
Accordingly, many genes are associated with stress-
related illnesses and anxiety. Genes related to HPA axis
activity as well as its regulation are of special interest in
this regard [10, 11]. For example, the NR3C1 gene en-
codes the glucocorticoid receptor (GR) and the single
nucleotide polymorphism (SNP) BclI rs41423247 has
been associated with an increased risk of major depres-
sive disorder [12]. The FKBP5 gene encodes the FK506
binding protein 51, which regulates GR sensitivity and
SNP rs1360780 associates with less efficient negative
feedback inhibition on the HPA axis [13, 14]. In
addition, SNP rs53576 in the oxytocin receptor gene
(OXTR) associates with depressive symptomatology [15,
16], stress-responsive activity [17] and increased anxiety
[18]. Furthermore, two polymorphisms in the serotoner-
gic system are often studied in association with anxiety
disorders and depression. First, a polymorphism (5-
HTTLPR) in the promoter region in the serotonin trans-
porter SLC6A4 gene results in either a long allele (l) or a
short allele (s) where the short allele associates with in-
creased levels of stress [19, 20] and a higher mental vul-
nerability to social stressors and chronic diseases [21].
Second, the SNP rs6295 in the transcriptional control
region of the serotonin receptor HTR1A gene has been
associated with severe depression and anxiety [22].
Anxiety disorders are considered the sixth largest con-
tributor to loss of non-fatal health globally [23] and
hence there is a need to identify risk-factors for anxiety
disorders. To date, the relationship between an individ-
ual’s anxiety and his/her genetic predisposition has been
poorly investigated in healthy individuals [24]. Studying
this relationship in healthy individuals removes the con-
founding of psychiatric symptoms, making it possible to
identify possible genetic risk-factors for anxiety. This is
important in the search for knowledge about which
individuals that may be more susceptible to developing
anxiety, and later on possibly also depression, and pro-
vide important information of the mechanisms under-
lying anxiety. Therefore, the aim of this exploratory
study was to investigate possible relationships between
genetic polymorphisms in genes important for the regu-
lation and activity of the HPA axis and self-assessed anx-
iety measured with the instrument State and Trait
Anxiety Inventory (STAI) in healthy individuals.
Methods
Participants and study design
DNA and STAI-responses were collected from 72
healthy volunteering participants, 37 females and 35
males (self-assessed health, non-clinical). Participants
were in the age range of 19–40 years old (mean age fe-
males = 24.6 years, SD = 4.6; mean age males = 26.8 years,
SD = 6.0). The participants were recruited from the stu-
dent population at Linköping University through an ex-
ploratory functional magnetic resonance imaging (fMRI)
based study with the overall aim to investigate the
neural, endocrine and genetic correlates of affective
touch. The self –assessment of the participant’s health
was done through questions asked to the participants.
Although the results presented in this paper focus on
the genetic aspects in connection with the STAI ques-
tionnaire, the inclusion and exclusion criteria were de-
signed to fit the overall aim of the fMRI based study.
The inclusion criteria were that couples should have
been in a romantic relationship for more than 1 year
and the female should be between 19 and 40 years. Ex-
clusion criteria were current use of contraceptives with
estrogen, pregnancy, as well as ongoing or recently com-
pleted hormone therapy. Since the fMRI based study
also included endocrine measurements it only included
participants that had been through puberty but had not
entered menopause, therefore the selection of the 19–40
year old participants.
Samples for DNA extraction were collected from both
female and male participants separately and all partici-
pants answered the STAI questionnaire one-on-one
without their partner present.
The study was approved by the Swedish Ethical Review
Authority through the regional Ethical Review Board in
Linköping, Sweden (2015/88–31) and all participants
gave written consent prior to participation.
DNA sampling and extraction
For the female participants, DNA was extracted from
venous blood collected in EDTA-tubes using the DNeasy
Blood and Tissue Kit (Qiagen, Hilden, Germany). For
the male participants, DNA was extracted from saliva
collected in collection tubes Oragene DNA OG-500
using the Oragene PrepIT L2G (DNA Genotek Inc.,
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Ontario, Canada). In the fMRI based study, through
which the participants were recruited (described above),
the female and male participants had different roles;
neural and endocrine responses were investigated in the
female participants while receiving touch from their
male partners. Therefore, DNA was obtained from dif-
ferent sources for female and male participants.
Polymorphism analysis
Each polymorphism was analyzed with the most suitable
and effective method as determined in our laboratory for
that particular polymorphism. Details follow below.
Serotonin transporter SLC6A4, 5-HTTLPR
The DNA-fragment in the promoter region of the
SLC6A4 was amplified by polymerase chain reaction
(PCR) using the following reaction mix: 40 ng of gen-
omic DNA, 0.5 mM of each primer as previously de-
scribed [21] (Table 1) and 10 μl GoTaq (Promega,
Madison, Wisconsin, USA) in a reaction volume of
20 μl. After an initial denaturation step for 5 min at
95 °C, 35 cycles of denaturation at 95 °C for 30 s, anneal-
ing at 59 °C for 40 s and extension of 72 °C for 50 s were
performed, followed by a final extension step of 72 °C
for 5 min. PCR-products were separated on a 3.5% agar-
ose gel to distinguish between the long allele (l), 440 bp,
and short allele (s), 396 bp.
Serotonin receptor gene HTR1A, rs6295
A 163-bp fragment containing the SNP at nucleotide
position HTR1A-1019 was amplified using the same
setup of PCR-reaction and program as for SLC6A4. The
reverse primer (Table 1) was designed to introduce a
variable restriction site depending on if there is a C or a
G in position HTR1A-1019, as previously described [22].
Subsequently, the introduced restriction site was de-
tected by digesting 10 μl of the PCR product with the
restriction enzyme BseGI in a total volume of 50 μl ac-
cording to the manufacturer’s instructions (ThermoFisher,
Waltham, Massachusetts, USA) and then separating the
product on a 3.5% agarose gel. The undigested fragment
(163 bp) carries the C and the digested one (146 bp/17 bp)
carries the G in the same position.
Glucocorticoid receptor gene, NR3C1, (BclI) rs41423247
The gene variant of NR3C1 SNP rs41423247 was analyzed
with droplet digital PCR (ddPCR) mutation detection
assay according to the manufacturer’s instructions (Bio-
Rad, Hercules, California, USA). Probes were designed to
discriminate between the alleles using two different fluor-
escent TaqMan probes (Table 1). The probe detecting the
C allele was marked with the fluorophore HEX and the
probe detecting the G allele was marked with the fluoro-
phore FAM (Bio-Rad, Hercules, California, USA).
FK506-binding protein 51, FKBP5, rs1360780
The gene was amplified in the following PCR-reaction; 40
ng DNA, 0,2mM dNTP, 0,4 mM of each primer (Table 1),
2 mM MgCl2 and 0,5 U of Taq-polymerase (New England
Biolabs, Ipswich, Massachusetts, USA) in a total volume of
25 μl. Primers were designed using Primer-BLAST
(https://www.ncbi.nlm.nih.gov/tools/primer-blast/). The
same PCR program as for SLC6A4 was used. The SNP
was then detected using Sanger sequencing.
Oxytocin receptor gene OXTR, rs53576
The gene variants of OXTR SNP rs53576 were analyzed
with ddPCR mutation detection assay according to the
manufacturer’s instructions (Bio-Rad, Hercules, California,
USA). Probes were designed to discriminate between the al-
leles A and G using two different fluorescent TaqMan
probes (Table 1). The probe detecting the A allele was
marked with the fluorophore HEX and the probe detecting
Table 1 Primers and probes used for the analyses of genetic polymorphisms in PCR and ddPCR
Gene SNP Primer Sequence 5′-3′/
ddPCR assay sequence (SNP in brackets)
Product (bp) Polymorphism
SLC6A4 5-HTTLPR F-ATGTCCCTACTGCAGCCTCC s(396)/l(440) (s)/(l)
R-AGTCCGCGCGGGATTC




NR3C1 rs41423247 CATTTGAACGTAAAATTTTGTTTTGCACCATGTTGACACCAATTCCTCTCTTAAAGAGATT C/G
[C/G]ATCAGCAGACATAACTTGTCTACTTTATGGCAAGAACCCTGTGAGCAAGACCTGTGTCTAA





Expected product size in base pairs depending on the polymorphism
SNP Single nucleotide polymorphism, F Forward primer, R Reverse primer, bp Base pairs
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the G allele was marked with the fluorophore FAM (Bio-
Rad, Hercules, California, USA).
Anxiety measurement
The participants’ self-assessed anxiety was measured
through STAI, a validated and frequently used question-
naire for measuring general anxiety [25]. There are two
subscales in STAI; one determines state anxiety (S)
which is a measure of how the person feels right now,
the other measures the trait anxiety (T) which is the
proneness for anxiety in the personality [25].
The STAI questionnaire is a self-administered test
with 40 questions. State anxiety items include statements
like “I am tense” and “I feel secure”. Trait anxiety items
include “I worry too much over something that doesn’t
really matter” and “I am a steady person”. Each item is
scored on a 4-point Likert scale. The range 1 to 4 is
from “not at all” to “very much so” for the STAI-S and
from “almost never” to “almost always” for the STAI-T,
with a total score range of 20 to 80. The median alpha
reliability coefficients in healthy individuals for the STAI
questionnaire (forms S and T) are 0.92 and 0.90, respect-
ively [26, 27].
Missing data in the STAI-S and STAI-T question-
naires (maximum two missing values) was handled with
hot deck imputation [28]. This was the case for two fe-
male participants, one in STAI-S (one item missing) and
one in STAI-T (one item missing).
Statistical analyses
All analyses were carried out using IBM SPSS 24 (SPSS
Inc., Chicago, USA). We applied independent t-test to
compare mean values of STAI-S and STAI-T between
sexes and Chi-square test for calculating Hardy-Weinberg
equilibrium for genetic polymorphisms. A probability level
of < 0.05 was considered statistically significant both for
testing gender differences in STAI and for Hardy-
Weinberg equilibrium.Due to gender differences in the
study participant’s STAI scores, the association analyses
between STAI scores and genotypes in the candidate
genes were carried out in female and male participants
separately, using independent t-test. To control for mul-
tiple comparisons in the association analysis, a Bonferroni
correction was performed, taking into account that five
different SNPs were tested. Therefore results with a p-
value < 0.01 were considered statistically significant for the
association analysis.
Results
State and trait anxiety
Self-reported measure of STAI-S was significantly higher
in female (N = 37, mean = 35.6, SD = ± 9.7) than in male
(N = 35, mean = 31.6, SD = ± 5.7) participants (t = 2.2,
df = 61.5, p = 0.030, two-tailed).
For STAI-T, we found significantly higher scores for
females (N = 37, mean = 40.3, SD = ± 9.8) compared to
males (N = 35, mean = 36.2, SD = ± 6.7) (t = 2.1, df =
67.5, p = 0.036, two-tailed). Therefore, female and male
participants were considered separately in the following
association analysis of the SNPs.
Allele frequencies
Allele frequencies of the five polymorphisms in the
whole cohort are shown in Table 2. Genotypes were dis-
tributed according to the Hardy-Weinberg Equilibrium
for all SNPs except for 5-HTTLPR (SLC6A4).
Association analysis
For the female participants there was a significant associ-
ation between the score for STAI-S and SNP rs41423247
in the NR3C1 gene. Carriers of the G allele had signifi-
cantly higher scores in STAI-S compared to carriers of the
C allele (t = − 3.077, df = 13.8, p = 0.008). No other signifi-
cant associations between the investigated SNPs and the
score of either STAI-S or STAI-T were detected for the
female participants (Figs. 1 and 2).
For the male participants, there was a significant asso-
ciation between the score for STAI-T and SNP rs53576
in the OXTR gene. Carriers of the A allele had signifi-
cantly higher scores in STAI-T compared to those that
were homozygous for the G allele (t = 2.911, df = 28.6,
p = 0.007). No other significant associations were detected
between the SNPs in this study and the score of either
STAI-S or STAI-T for the male participants (Figs. 1 and 2).
Discussion
In this study, we investigated genetic risk-factors for
anxiety by examining possible relationships between
SNPs in genes important for the regulation and activity
of the HPA axis and self-assessed anxiety measured with
STAI in healthy individuals. We found significant
gender-specific associations between STAI-S/T and
SNPs in the NR3C1 gene and the OXTR gene.
Female participants in our study scored significantly
higher in both STAI-S and STAI-T compared to male
participants. This was not unexpected, since females
often exhibit higher scores in both STAI-S and T in self-
reported assessments of anxiety, which may contribute to
a higher incidence of anxiety disorders in women [29, 30].
Factors that contribute to such gender differences are dif-
ferent exposure to sex-hormones, particularly estrogens,
and different social expectations and experiences [29]. An-
other aspect that might contribute to differences in STAI-
scores between genders is that females may be more prone
to admit anxiety than males, as doing so may be experi-
enced as a threat to masculinity [31]. It is also possible
that the preparations for the fMRI based study, through
which our participants were recruited, for example
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invasive blood draws, had some effects on the anxiety
levels of the females, especially for the STAI-S scores.
The association analyses showed a significant associ-
ation in the female participants between STAI-S and the
SNP rs41423247 in the NR3C1 gene, which codes for
the glucocorticoid receptor. Females with the CG/GG
genotypes had significantly higher scores in STAI-S
compared to females with the CC genotype. It has previ-
ously been shown that the G allele associates with in-
creased sensitivity to glucocorticoids [32] and therefore
an increased activity in the HPA axis, which could con-
tribute to an increased risk of anxiety. In addition, an-
other SNP on the same gene (rs6195) is associated with
major depressive disorders in women, but not men [12].
These combined results strengthen the hypothesis that
polymorphisms within the NR3C1 gene can serve as
genetic risk-factors for anxiety, at least state anxiety.
Interestingly, these polymorphisms appear to be of spe-
cial importance in females.
For the male participants, there was a significant asso-
ciation between high scores in STAI-T and the A allele
in the SNP rs53576 of the OXTR gene. Males with at
least one A allele had significantly higher scores in
STAI-T compared to males with the GG genotype. This
is in agreement with previous studies where the GG
genotype associates with prosocial behavior [16] whereas
the A allele is associated with anxiety and depression
[15]. Therefore, SNP rs53576 in the OXTR gene emerges
as a genetic risk-factor for trait anxiety which may be es-
pecially important for males.
Table 2 Allele and genotype frequencies of the five polymorphisms studied
Polymorphism Allele Allelle frequency Genotype Genotype frequency Hardy-Weinberg Equilibrium
5-HTTLPR
N = 72
s 0.451 s/s 0.264 χ2 = 4.26 p = 0.04




C 0.507 CC 0.261 χ2 = 0.01 p = 0.91




C 0.364 CC 0.086 χ2 = 2.60, p = 0.11




C 0.696 CC 0.507 χ2 = 0.83, p = 0.36




A 0.357 AA 0.072 χ2 = 2.32, p = 0.13
G 0.643 AG 0.551
GG 0.373
Fig. 1 Associations between the different polymorphisms studied and mean scores (SEM) of STAI-S. * p < 0.01, N/A = only one participant
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In contrast, we found no association in neither males
nor females between STAI-S/T and the SNP rs1360780
in the FKBP5 gene, which codes for the FK506 binding
protein 51 that regulates GR sensitivity. Ising et al. only
found a relationship between FKBP5 polymorphism and
self-reported anxiety after a psychological stress test
[14]. Since our study setup and aim did not include such
a test, we could not establish any relationship between
the polymorphism in the FKBP5 gene and self-assessed
anxiety after psychological stress. This indicates that
polymorphisms in the FKBP5 gene might be more im-
portant to study under stressful conditions and less im-
portant from a preventive perspective.
Furthermore, we did not find any association between
STAI-S/T and the polymorphisms studied in the seroto-
nergic system (5-HTTLPR in SLC6A4 and rs6295 in
HTR1A). Previous reports have also failed to determine
an association between the polymorphisms in SLC6A4
regarding depressive symptoms among humans with
high social support (social compensation) [33, 34]. In
our study, the inclusion criterion of “being in a romantic
relationship” might have excluded individuals with low
social support. The high social support among our par-
ticipants may thus have influenced their self-reported
anxiety, which might explain why we could not deter-
mine an association with the different genotypes in the
serotonergic system.
In summary, our results point towards a gender differ-
ences in the polymorphisms in the genes controlling ei-
ther the activity (NR3C1 gene) or the regulation (OXTR
gene) of the HPA axis. Our female participants clearly
scored significantly higher in the STAI questionnaire
than did their males counterparts. Previous studies have
also demonstrated gender differences in the HPA axis
[35] and that these differences can play a role in differ-
entially forming the personality traits of females and
males [36]. The reason for these gender differences are
not yet fully understood, but the effects of sex-hormones
on neurological development and function of different
endocrine systems in humans may play a role [29]. Inter-
estingly, estrogen has been identified as one important
factor for gender differences in anxiety, since it has
modulating effects on the HPA axis. However, the effects
vary according to studies and preclinical and clinical
populations [37]. In our study, we controlled for use of
contraceptives with estrogen, pregnancy, as well as
ongoing or recently completed hormone therapy. There-
fore, any gender differences that might be due to differ-
ences in estrogen levels are influenced by endogenous
estrogen levels only. In addition, both female and male
participants were within the same age range which
makes differences between genders not attributed to age
differences. Our results highlight the importance of in-
vestigating female and male participants separately in
these types of studies.
The validity of genetic association studies depends
on the genotypes being in Hardy-Weinberg equilib-
rium. Violations of the Hardy-Weinberg equilibrium
might signal errors in the analyzed data and problems
in the interpretations of the genetic association data
[38]. One limitation of our study is the limited num-
ber of participants, but since all genotypes except one
were in Hardy-Weinberg equilibrium our study sam-
ple is likely to be representative and applicable to the
population.
A novelty with our study is the preventive approach
including only healthy, non-clinical participants. This
means that the results presented here are not con-
founded by psychiatric health problems and can there-
fore help in identifying possible genetic risk-factors for
anxiety. To further investigate the importance of the ge-
notypes identified in our study, it would be interesting
to proceed with future case-control studies with patients
that suffer from anxiety.
Fig. 2 Associations between the different polymorphisms studied and mean scores (SEM) of STAI-T. * p < 0.01, N/A = only one participant
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Conclusion
This study shows that SNP rs41423247 in the NR3C1
gene and SNP rs53576 in the OXTR gene are associated
with self-assessed anxiety in healthy individuals in a
gender-specific manner. This makes these polymor-
phisms candidates for genetic risk-factors for anxiety.
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